Sign In
Buy LLY
$1,185.71
-6.23 (-0.523%)
At Close: Aug 07, 2026
These 2 Pharma Stocks Might Face Off Soon -- but They Could Both Win
08:15am, Sunday, 14'th May 2023
Two new medicines are going to compete for the Alzheimer's therapy market. Eli Lilly's candidate appears to be more effective, but it isn't approved yet.
3 Growth Stocks to Buy and Hold
08:00am, Saturday, 13'th May 2023
Axsome's relatively new approval was only the first step in an exciting growth story. Eli Lilly has a strong pipeline that will help improve its already-solid financial results.
Will Eli Lilly Be a Trillion-Dollar Stock by 2030?
07:35am, Saturday, 13'th May 2023
The market is pricing Eli Lilly's stock as if its earnings are going to grow like wild, and they might. Its pipeline could furnish the company with plenty of near-term growth.
Eli Lilly on track to close with a higher market cap than J&J for first time since 1997
12:55pm, Friday, 12'th May 2023
Eli Lilly & Co. was on track Friday to close with a greater market capitalization than Johnson & Johnson for the first time since October 1997, according to Dow Jones Market Data.
Here's What Eli Lilly's Latest Clinical Win Means For Investors
06:20am, Friday, 12'th May 2023
Eli Lilly's donanemab just proved effective in treating Alzheimer's disease in a pivotal clinical trial. This should be yet another key addition to Eli Lilly's expanding lineup.
Prescription-drug costs in spotlight as pharmacy benefit reform advances in Senate
02:46pm, Thursday, 11'th May 2023
A bipartisan effort to rein in prescription drug prices advanced Thursday as a key U.S. Senate committee approved a bill aimed at reforming pharmacy benefit managers.
Here's Why Eli Lilly's Alzheimer's Drug Could Be the Real Deal
10:07am, Thursday, 11'th May 2023
Trial data show that donanemab may potentially slow the progression of Alzheimer's. The drug candidate has also been effective in reducing amyloid plaque in the brain.
Eli Lilly CEO vows not to raise insulin prices again, while Novo Nordisk and Sanofi hedge
05:37pm, Wednesday, 10'th May 2023
He was the only executive to do so before a Senate Health Committee hearing that also included the CEOs of Novo Nordisk and Sanofi.
Bearish Headwinds Have Evolved to Bullish Tailwinds: This Industry Soars
02:27pm, Wednesday, 10'th May 2023
The headline inflation figure rose at the slowest rate in more than two years.
3 Dividend Stocks to Buy as the Healthcare Sector Booms in 2023
06:45am, Tuesday, 09'th May 2023
After a relatively impressive 2022, the best healthcare dividend stocks have hit a temporary rough patch this year. However, savvy investors shouldn't let this blip deter them from wagering on this de
Why Did Eli Lilly Stock Jump 15% in April?
10:56am, Monday, 08'th May 2023
Eli Lilly published positive clinical trial results on a weight-loss drug and an early-stage Alzheimer's treatment candidate. Though its Q1 results fell short of analysts' estimates, investors were pl
Where Will Eli Lilly Be in 3 Years?
05:57am, Monday, 08'th May 2023
Eli Lilly's near-term outlook is quite favorable. The only major constraint it faces is competition in several drug markets.
3 Things About Eli Lilly That Smart Investors Know
05:05am, Monday, 08'th May 2023
The next couple of years will see Eli Lilly's top and bottom lines swell. Its debt load looks like more of a problem than it actually is.
2 Top Healthcare Stocks Defying the Bear Market
08:14am, Sunday, 07'th May 2023
Eli Lilly's tirzepatide could be a weight-loss blockbuster. Merck continues to add indications for oncology therapy Keytruda.
2 Best Biotech Stocks to Buy Right Now
07:55am, Saturday, 06'th May 2023
Eli Lilly and Amgen both boast exceptional product portfolios and pipelines. The two companies pay growing dividends to shareholders.
